Livingstone Health Holdings says it has been appointed by the Ministry of Health (MOH) to lead the procurement of Sinovac Biotech’s vaccine on behalf of private healthcare institutions in Singapore.
The company has been granted approval to import and supply the vaccines via the special access route by the Health Sciences Authority (HSA) and MOH on Sept 15.
The vaccines will be available from Sept 24 at all four clinics under Livingstone’s primary healthcare arm, Phoenix Medical Group.
The vaccines will also be available at 13 other clinics islandwide including those from Fullerton Health.
See also: Livingstone Health signs MOU with China’s CMEC and CPG Consultants
In addition, Livingstone’s non-executive chairman, CEO and chief business officer, Teh Wing Kwan, Dr Wilson Tay and Dax Ng have personally committed to purchase and donate up to 500 doses of the Sinovac vaccines.
See also: BioNTech beats estimates as vaccine maker pursues more diseases
The vaccines will be administered free of charge for the first 250 seniors above 60 years old.
The recipients will have to be registered, with their interest confirmed through Phoenix Medical Group.
Shares in Livingstone closed 0.2 cent lower or 1.18% down at 16.8 cents on Sept 14.
Photo: Albert Chua/The Edge Singapore
